Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis

Mise à jour : Il y a 4 ans
Référence : NCT00546663

Femme et Homme

Extrait

This is an open-label pilot study of the safety and tolerability of 7% hypertonic saline inhaled twice daily for 14 days in infants with CF, 12 to 30 months of age.


Critère d'inclusion

  • Cystic fibrosis

Liens